Innovation at CERC: Where visionary minds design clinical trials that matter
To safeguard our founding spirit and ensure we continuously push the boundaries, we have established dedicated Innovation Groups. These are dynamic, collaborative think-tanks comprising our founding KOLs, internal experts, and external visionaries. Each group is laser-focused on a transformative field, designing trial methodologies that are as advanced as the therapies they evaluate.
Born from KOLs. Driven by Unmet Needs. Delivering Impactful Care
Structural Heart Disease
Advancing minimally invasive valve and structural therapies.
Innovation Group led by Prof. Bernard PRENDERGAST and facilitated by Laure MORSIANI.
Focuses on diverse patient needs across Europe and Asia
Designs: original, investigator-driven studies pioneering new therapeutic approaches.
Key Achievement: START YOUNG study – early valve intervention in younger patients.
Coronary Interventions
Transforming revascularization through innovation.
Innovation Group led by Dr. Pieter SMITS and facilitated by Phani Krishna KONDAMUDI.
Focused on optimizing visualization and treatment of coronary artery disease.
Collaboration strengthens and accelerates new concepts.
Key Achievement: Leave Nothing Behind study exploring the benefits of DCB and BRS.
Renal Denervation
Redefining hypertension management.
Innovation Group led by Prof. Felix MAHFOUD and facilitated by Estelle DARRAU.
Promotes adoption of renal denervation in cardiology.
Designs innovative studies and fosters multidisciplinary collaboration.
Focus: Next-generation trials in a re-emerging field.
Pharma
Integrating pharmacology, imaging, and innovation.
Innovation Group led by Prof. Philippe Gabriel STEG and facilitated by Ute WINDHÖVEL.
Builds partnerships with pharma to explore new treatment mechanisms.
Develops investigator-led studies in cardiovascular pharmacology.
Goal: Translate emerging therapies into measurable patient benefit.
New Trial Design
Making trials smarter and faster.
Innovation Group led by Dr. Pieter SMITS and facilitated by Van Tuan NGUYEN.
Designed to shape the trials for the future
Embracing Artificial Intelligence and Deep Learning
Making future trials more cost effective
Partner with the Innovators!
Are you ready to run a study that doesn't just meet endpoints, but sets new standards? Let's co-create the future of cardiovascular medicine.
